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Abstract
In Streptococcus mutans, the global response regulator CovR plays an important role in biofilm formation, stress-tolerance
response, and caries production. We have previously shown that CovR acts as a transcriptional repressor by binding to the
upstream promoter regions of its target genes. Here, we report that in vivo, CovR activates the transcription of SMU.1882,
which encodes a small peptide containing a double-glycine motif. We also show that SMU.1882 is transcriptionally linked to
comA that encodes a putative ABC transporter protein. Several genes from man gene clusters that encode mannose
phosphotranferase system flank SMU.1882 -comA genes. Genomic comparison with other streptococci indicates that
SMU.1882 is uniquely present in S. mutans, while the man operon is conserved among all streptococci, suggesting that a
genetic rearrangement might have taken place at this locus. With the use of a transcriptional reporter system and semi-
quantitative RT-PCR, we demonstrated the transcriptional regulation of SMU.1882 by CovR. In vitro gel shift and DNase I
foot-printing analyses with purified CovR suggest that CovR binds to a large region surrounding the -10 region of the P1882.
Using this information and comparing with other CovR regulated promoters, we have developed a putative consensus
binding sequence for CovR. Although CovR binds to P1882, in vitro experiments using purified S. mutans RpoD, E. coli RNA
polymerase, and CovR did not activate transcription from this promoter. Thus, we speculate that in vivo, CovR may interfere
with the binding of a repressor or requires a cofactor.
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Introduction
Streptococcus mutans, which is a part of the normal flora of the
human oral cavity, is considered to be the primary etiological
agent in the formation of dental caries [1,2]. Dental caries is a
global health problem that affects from 60–90% of school
children, as well as many adults in industrialized countries
[3,4,5]. Although not fatal, dental caries is a costly disease, leading
to annual expenditure in billions of dollars in the U.S. alone. S.
mutans is also a leading cause of bacterial endocarditis, with greater
than 14% of viridians streptococcus-induced endocarditis trig-
gered by infections of S. mutans [6]. For colonization in the oral
cavity, S. mutans metabolizes the dietary carbohydrates ingested by
its host to produce glucan and to anchor itself to the tooth surface,
forming densely populated microbial biofilms known as dental
plaque that includes hundreds of species of other oral bacteria [7].
The capacity of S. mutans to persist and to maintain a dominant
presence in the oral cavity is due to its ability to adapt and respond
to a variety of adverse growth-limiting conditions and production
of antimicrobial peptides known as mutacins [8,9].
Bacteria have evolved several strategies to adapt to unexpected
changes in their extracellular environment, but the predominant
mechanism is the so-called two-component signal transductions
system (TCS) [10]. TCSs allow bacteria to coordinate a focused
and appropriate physiological response to counter the effects of
specific extracellular stimuli. A TCS typically consist of two main
components: a membrane-bound sensor histidine kinase, which
senses environmental cues, and a cytoplasmic response regulator,
which upon activation by the cognate histidine kinase, elicits the
appropriate cellular response, usually by binding to specific DNA
target sequences, and acting as a transcriptional regulator to
modulate the expression of various genes, depending on the
growth condition [10].
The TCS CovRS has been extensively studied in streptococcal
spp., particularly in group-A-streptococcus (GAS) [11,12,13,14].
CovRS directly or indirectly regulates approximately 15% of the
GAS genome, including many virulence genes. CovRS also
mediates the growth of GAS during periods of iron starvation as
well as growth in the bloodstream [14,15,16]. The vast majority of
the CovR regulon is repressed by CovR [17]. CovS is thought to
be the cognate sensor kinase for the phosphorylation or
dephosphorylation of CovR, which typically functions as a
transcriptional repressor [18]; environmental stimuli, particularly
during periods of stress, are recognized by CovS, which regulates
the activity of the global response regulator CovR [11]. Although
CovR regulates the expression of common sets of genes in different
GAS strains, there are also variations in the CovR regulon that
arise between strains [19,20]. CovRS is also associated with
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streptococcus (GCS) [17,21,22]. Approximately 6% of the genome
of GBS is regulated by CovRS, including some virulence factors
[22,23]; as with GAS, the CovR regulon is mostly repressed by
CovR.
S. mutans encodes 14 putative TCS in its genome [24,25];
however, unlike other streptococcal spp., S. mutans does not encode
covS, but does express CovR, also known as GcrR or TarC
[26,27,28]. Therefore, CovR appears to be an orphan response
regulator in S. mutans. As with other streptococcal spp., CovR is an
important global response regulator in S. mutans, as it regulates the
expression of various virulence genes that are essential for biofilm
formation, such as the glucosyltransferases (gtfB/C), glucan-binding
proteins C (gbpC), and also of its own expression [27,29,30].
In GAS, CovR typically functions as a transcriptional repressor
[14,17]. With respect to S. mutans, while CovR negatively regulates
the expression of the afore-mentioned genes, our data indicates
that CovR can also function as an activator of gene expression
(Biswas, unpublished) one such example is an open reading frame
encoded by SMU.1882. In order to gain further insight into the
importance of CovR in the physiology of S. mutans, and the
mechanism of gene regulation, we begin by having a look at the
regulation of SMU.1882 by CovR. In this communication, we
report that CovR, under in vivo conditions, activates the expression
of SMU.1882. CovR directly binds to the putative promoter
region of SMU.1882 and protects a region containing putative
promoter elements against DNase I digestion. However, binding
of CovR to the promoter of SMU.1882 did not stimulate
transcription under in vitro conditions, suggesting other factors
may be involved under in vivo conditions.
Results
SMU.1882 is unique to S. mutans
Bioinformatics analysis of SMU.1882 gene (354-bp) reveals that
it encodes a hypothetical protein of 117 amino acid residues in
length containing three double-glycine (GG) motifs, one of which
is at position 23. A recent in silico analysis suggests that the
SMU.1882 peptide is a secretory molecule [31]; the GG motif at
position 23 is thought to be the site at which the cleavage occurs.
However, our analyses of the genome of S. mutans along with other
streptococcal spp., including S. agalactiae, S. gordonii, S. mitis, S.
pneumoniae, and S. pyogenes, S. thermophilus, using software at the
Comprehensive Microbial Resource website (http://cmr.jcvi.org/
tigr-scripts/CMR/CmrHomePage.cgi), revealed that SMU.1882
is unique to S. mutans, as it is apparently not found in these
streptococcal spp. (data not shown); however, several small GG
containing peptides and homologs of the upstream SMU.1883
gene are present in some streptococci. While SMU.1882 and the
adjacent comA homolog, SMU.1881, are unique to the S. mutans
strains, the flanking genes, which encode mannose-phosphotrans-
ferase system (man-PTS) are very well conserved among
streptococci and other Firmicutes [32].
Transcriptional organization of the SMU.1882 locus
A schematic diagram of the SMU.1882 locus and the genes in
its vicinity are shown in Fig. 1A. Sequence analysis, confirmed
using BPROM online software (Prediction of bacterial promoters,
Softberry, http://linux1.softberry.com), indicates the presence of
putative -35 (GTGAGT) and -10 (TATAAT) box motifs 151- and
127-bp, respectively, upstream of the putative start codon with a
putative ribosomal binding site (AGAGA) 11-bp upstream of
the start codon. A putative rho-independent terminator sequ-
ence (GCCTGACTACATAGATGTCAGGC) was identified at
position 402-bp downstream of SMU.1882 by TransTerm
(transterm.dev.java.net) program.
Since the transcripts of many CovR regulated genes have
relatively shorter half-life, we therefore evaluated the stability of
SMU.1882 transcript. The results of the mRNA stability assay
indicated that the chemical half-life of the SMU.1882 transcript
was approximately 2–3 minutes (Fig. 1B). Northern blot analysis
indicated that there was one major band of 1.5-kb (which was used
for the stability determination) and two other minor bands of
approximately 3.0- and 6.0-kb, which constituted less than 5% of
the total signal (Fig. 1C), suggesting that other genes may be
cotranscribed along with SMU.1882. To determine whether the
downstream comA (SMU.1881) was transcriptionally linked to
SMU.1882, PCR analysis was performed using cDNA, with
chromosomal DNA and RNA as the positive and negative
controls, respectively. As shown in Fig. 1D, SMU.1882 appears
to be transcriptionally linked with comA, which would account for
the presence of the 3-kb transcript seen in the northern blot. This
product could be generated due to read-through transcription
from the SMU.1882 promoter.
CovR upregulates transcription from P1882 in vivo
To gain insight into the link between CovR and expression of
SMU.1882, sqRT-PCR was used to quantify the level of CovR-
dependent expression of SMU.1882. Wild-type S. mutans UA159,
and its isogenic DcovR derivative, IBS603, were grown to mid-
exponential phase (KU70), followed by harvesting and extraction
of RNA. The gyrA gene was included as control to ensure that
equivalent amounts of RNA were being used for each reaction.
Fig. 2A shows that higher levels of SMU.1882 transcript are being
produced from the wild-type strain compared to the covR mutant
strain, with approximately three-fold difference in expression of
SMU.1882; complementation of the DcovR mutant strain with
plasmid pIB30 (IBS603/pIB30), which carries the full length, wild-
type covR gene in trans, restores expression of SMU.1882 to the
wild type level. Since SMU.1883 gene appears to be divergently
transcribed from the promoter upstream of the SMU.1882, we
also measured the level of SMU.1883 transcript by sqRT-PCR.
We found no significant difference between the wild type and the
covR mutant strains. Thus, although SMU.1882 and SMU.1883
share the same intergenic region, CovR appears to only activate
transcription of the SMU1882 gene. The results of the sqRT-PCR
were further supported by real-time RT-PCR analysis. As shown
in Fig. 2B, we found that the transcript level in the covR mutant
strain was approximately 2.5-fold lower compared to the wild type
strain.
To confirm that CovR can regulate SMU.1882 promoter at a
non-native locus, we used a transcriptional reporter fusion for
analysis to avoid any cis-effect that may alter the gene expression.
Transcriptional fusion reporter strains were constructed by cloning
the putative promoter region of SMU.1882 into plasmid pIB107,
which contains a promoterless gusA gene [29]. This construct was
inserted at the SMU.1405 locus, which is well separated from the
native SMU.1882 locus [29]. When the wild type, covR-deletion
mutant (IBS606), and complemented covR-deletion mutant
(IBS606/pIB30) strains, containing the P1882-gusA transcriptional
fusion reporter, were assayed for Gus activity. As shown in Fig. 2B,
GusA activity was significantly reduced in the mutant strain
IBS606, indicating that CovR is required to activate transcription
from P1882. However, GusA activity was restored to the parental
level when the DcovR strain was complemented with covR in trans
(IBS606/pIB30). Taken together, the results of the RT-PCR
analyses and the reporter fusion assays indicate that expression of
SMU.1882 is up regulated in the presence of CovR.
Gene Activation by CovR in S. mutans
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Electrophoretic mobility shift assays (EMSA) and DNase I
protection assays were used to demonstrate the specific binding of
CovR to the putative promoter region of SMU.1882, P1882.As shown
in Fig. 3A, incubation of the P1882 DNA fragment with increasing
amounts of CovR leads to retardation in the mobility of the DNA
fragment. Incubation of the
32P-labeled P1882 fragment with a 25-fold
higher amount of non-labeled P1882 DNA fragment resulted in no
shifting of the labeled band, while the addition of a 25-fold higher
amount of a DNA fragment containing the promoter region for the
nlmA gene (PnlmA), which encodes a peptide component of mutacin IV
and is not regulated by CovR, did not inhibit shifting of the CovR-
bound P1882 fragment (Fig. 3A). This demonstrates that CovR binds
specifically to the promoter region of SMU.1882.
DNase I protection assays were performed to determine the portion
of P1882 that binds to CovR, using the same P1882-CovR mixtures
prepared for EMSA, as described above. Analysis of the gel indicates
that CovR binds to the DNA fragment from position -200 to -1,
relative to the start codon, and protects this region against digestion by
DNase I (Fig. 3B). This region also includes the putative ribosomal
binding site, AGAGA, which is found 13-bp upstream of the start
codon, as well as the putative -35 and -10 box regions. Taken together,
the results of the EMSA and DNase I analyses suggest that CovR
activates the expression of SMU.1882 by specifically binding to P1882.
Figure 1. Transcriptional analysis of SMU.1882 locus. (A) Schematic diagram of SMU.1882 locus. Open reading frames (orf) are designated by
block arrows, and their orientations indicate the direction of transcription. The sequence upstream of SMU.1882 orf is shown below the diagram. (B)
Stability of SMU.1882 transcript. The stability of SMU.1882 transcript was measured using cultures at mid-exponential growth phase (70 KU). RNA was
extracted from S. mutans wild type strain UA159 at the time (in minutes) indicated above the lanes following addition of rifampin to block de novo
transcription. The mRNA decay curve was plotted as a function of time (in minutes). (C) Northern blotting was carried out using the SMU.1882 orf as a
probe. A major band of 1.5 kb and two minor bands (3.0 kb and 6.0 kb) were obtained. (D) Transcriptional linkage analysis. Transcription linkage
between SMU.1882/comA, and SMU.1884/SMU.1882 was analyzed using the primer pair 1+2 and 3+4, respectively. K-DNA denotes genomic DNA. (E)
Amino acid sequence encoded by SMU.1882. The conserved GG-motif, the putative site for the signal peptide cleavage, is underlined.
doi:10.1371/journal.pone.0015528.g001
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quantitative RT-PCR analysis of SMU.1882, SMU.1883, and gyrA for the
strains UA159, DcovR (IBS603) and DcovR complemented with pIB30
(IBS603/pIB30). The gyrA gene was included as an internal control to
ensure that equal amounts of RNA were loaded per lane. Experiments
were repeated at least twice with two independent RNA isolations. (B)
Quantitative real-time PCR analysis of SMU.1882 transcript in wild type,
DcovR (IBS603) and DcovR complemented with pIB30 (IBS603/pIB30).
The expression of SMU.1882 was normalized to the expression level of
gyrA as an internal reference. Relative fold changes in gene expression
are represented as histograms with error bars. Each histogram is the
mean of four biological replicates. (C) Reporter fusion assay. The
putative promoter of SMU.1882 was fused to a promoter-less gusA
reporter gene and inserted into the S. mutans UA159 chromosome.
Expression driven from the promoters was evaluated by measuring Gus
activity. Gus values were measured from at least three independent
cultures; mean values with standard deviations are shown.
doi:10.1371/journal.pone.0015528.g002
Figure 3. CovR binds to SMU.1882 promoter region. (A) In vitro
binding of CovR to the promoter of SMU.1882. EMSA was performed
with His-tagged CovR as described in the text. Lanes: 1, no CovR; 2,
14.97 pmol CovR; 3, 29.94 pmol CovR; 4, 59.88 pmol CovR; 5, 89.82 pmol
CovR; 6, 119.76 pmol CovR; 7 and 8, 29.94 pmol CovR. 0.5 pmol labelled
P1882 was used in all the reactions. 25-fold molar excess of cold P1882
and PnlmA were used in lanes 7 and 8 respectively. B: bound DNA; F: free
DNA. (B) DNase I protection assay of the putative SMU.1882 promoter.
0.5 pmol labelled P1882 was used in all the reactions. Lane: 1, no CovR; 2,
59.88 pmol CovR; 3, 89.82 pmol CovR; 4, 119.76 pmol CovR; 5, 187.125
pmol CovR. Footprints were run in an 8% sequencing gel next to
sequencing ladders (G, A, T, and C). CovR binding regions are indicated
by vertical lines at the side of the sequencing gels, while horizontal lines
mark -10 and -35 regions of the promoter. All experiments were carried
out at least thrice, and a representative gel is shown.
doi:10.1371/journal.pone.0015528.g003
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specific
Bioinformatics analysis at the CMR website indicates that gene
SMU.1882 is not found in streptococcal spp. outside of S. mutans
strain UA159; however, it was not known whether SMU.1882 is
conserved in other isolates of S. mutans. To determine whether
SMU.1882 is present in other S. mutans strains, we used Southern
hybridization to verify whether SMU.1882 was present in other
isolates, from three different serotypes (c, e, and f) of S. mutans.A
32P-
labeled DNA fragment containing a 267-bp internal SMU.1882
sequence derived from the genome of UA159 was used as a probe
against the XmnI-digested chromosomal DNA from a number of S.
mutans isolates. The results of the Southern hybridization analysis are
shown in Figure 4A. Sequence analysis predicts that, a diagnostic 6-
kb DNA fragment will be generated after XmnI-digestion UA159
genomic DNA. As shown in Fig. 4A, with the exception of strains
T8,109C,and UA130that did not producebands,the hybridization
pattern observed for the majority of the isolates was identical with
that of UA159 (6 kb); however, the observed band for strain
OMZ175 was 4-kb. The overall results suggest that SMU.1882 is
conserved in most, but not all, strains of S. mutans.
GS-5 and NG-8 are two other S. mutans strains that have been
characterized to some degree. To determine whether CovR-
activation of SMU.1882 is unique to strain UA159, sQRT-PCR
analysis was performed on S. mutans strain GS-5 and its isogenic
covR mutant derivative, IBS07; the results indicate that CovR-
dependent regulation of SMU.1882 is not limited to strain UA159.
Fig. 4B shows that there is a 1.8 to 2.0-fold drop in expression of
SMU.1882 in IBS07 relative to the wild-type GS-5. Complemen-
tation of the covR mutant with full-length covR (IBS07/pIB30), in
trans, restores the expression of SMU.1882 slightly higher than the
wild-type level. sQ-RT results were further confirmed by real-time
RT-PCR that showed a similar reduction of SMU.1882 transcript
in IBS07 as compared with GS-5 (Fig. 4C). Furthermore,
inactivation of covR in S. mutans strain NG8 also indicates that
CovR activates the expression of SMU.1882 in this strain (Fig. 4D).
Taken together, the results suggest that CovR regulation of
SMU.1882 expression is not limited to the UA159 strain alone and
the degree of reduction of SMU.1882 transcript in different strains
appears to be similar.
CovR does not activate expression of SMU.1882 in vitro
In vitro transcription assays were performed to demonstrate
direct activation of expression from P1882. A 319-bp fragment,
containing the first 82-bp of SMU.1882 as well as the putative
promoter elements, was PCR-amplified from the S. mutans
chromosome, and used as template for the in vitro transcription
run-off assays, along with a 319-bp fragment containing Pami that
was amplified from pIB163 which was used as a control. To
perform the reaction, E. coli RNA polymerase core enzyme was
reconstituted with purified his-tagged RpoD from S. mutans.A s
shown in Fig. 5, addition of reconstituted RNA polymerase
holoenzyme, but not the core enzyme, generated expected size
bands of 193-nt and 158-nt when P1882 and Pami, respectively, were
used as template (lanes 2 and 7). However, the addition of CovR
did not lead to any observable increase in transcription from P1882.
The level of transcription in the reaction mixes containing purified
CovR (lanes 4–6) did not appear to be any different than the lanes
that did not contain CovR (Lane 3).
Discussion
Many bacterial TCS activate gene expression, but CovR in
GAS and GBS typically acts to repress gene expression; of the 271
genes regulated by CovR in GAS, only 26 are upregulated by
CovR (during late exponential phase) [17]. Our own data suggest
that CovR of S. mutans predominantly functions as a repressor
[27,29,30]. However, CovR can also act as a transcriptional
activator in streptococci, either directly or indirectly [17,33]; and
in the case of S. mutans, one such gene that appears to be activated
by CovR is SMU.1882. The goal of this study was to elucidate the
nature of the regulatory interaction between CovR and
SMU.1882.
In GAS, binding of CovR to the promoter sequences of the has,
covR, and dppA, under in vitro conditions, requires the presence of a
consensus binding sequence (CB) ATTARA, or the near-CB
ATTAAC [33,34,35]. However, the importance of this sequence
in the promoter regions of S. mutans genes for CovR-binding is
unclear, since the ATTARA sequence is not found in the
intragenic sequences of some CovR-regulated genes of S. mutans
[29,30]. Given the high degree of similarity between CovR of GAS
and S. mutans, it is surprising that the ATTARA sequence is not
more prevalent in the promoter regions of S. mutans genes. A single
ATTAAA sequence is found 67-bp upstream of the start codon;
whether this sequence is a CB for P1882 remains to be studied.
However, mutation of the ATTARA sites of PdppA in GAS did not
inhibit transcription in vivo, although the ATTARA sequences
appeared to be essential under in vitro conditions [33]. As such, it is
possible that the lone ATTARA site in P1882 may not function as a
CB under in vivo conditions.
In S. mutans, CovR has been shown to bind directly to five
promoters, including P1882,t om o d u l a t eg e n ee x p r e s s i o n[ 2 7 , 2 9 , 3 0 ] .
However,a consensusDNA binding sequence(CBS) motiffor CovR
has not been developed. In an effort to create a CBS for CovR, we
have used GLAM2 [36] program on the five promoter sequences
that are regulated by CovR to develop an optimized position weight
matrix for CovR binding. We obtained four different CBSs with
overall weight score varied from 78.4 to 67.8. The CBS with the
highest score and the location of the CBS on five promoter regions
are shown in Fig. 6. Interestingly for one promoter, PgtfC,t h i sC B S
was present twice, one on the sense and another on the nonsense
strands. However, the significance of this newly derived CBS in
CovR binding needs to be verified experimentally.
The results of the sQRT-PCR and reporter expression analyses
demonstrate that CovR is required for the increased expression of
P1882 under in vivo conditions, while in vitro gel shift and DNase I
protection assays show that CovR directly binds to a portion of the
intragenic region upstream of SMU.1882. Taken together, the
results suggested to us that CovR might play a direct role in the
activation of expression of SMU.1882. However, the results of the
in vitro transcription assays appear to indicate otherwise, since
activation of SMU.1882 expression was not observed with the
addition of purified CovR. Our results are similar to the
observations made with the in vitro transcription reactions with
PdppA of GAS, where CovR appeared to be required for in vivo
activation of transcription of dppA, but could not activate
transcription under in vitro conditions [33]. It is always possible
that the in vitro transcription reaction conditions were much
different than the in vivo conditions or the role of CovR may not be
to directly activate transcription of SMU.1882, but to displace
other proteins that may be inhibiting or silencing transcription of
SMU.1882. It is possible that the RpoD (sigma factor) does not
functionally interact with E. coli RNA core polymerase and thus
CovR’s effect is not seen in vitro. However, we believe this
scenario is unlikely since several heterologous sigma factors are
shown to functionally interact both in vivo and in vitro with E. coli
RNA polymerase [37,38,39]. Thus, how CovR activates
SMU.1882 expression in vivo needs to be elucidated.
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PLoS ONE | www.plosone.org 5 November 2010 | Volume 5 | Issue 11 | e15528Figure 4. Presence of SMU.1882 locus in different strains of S. mutans. (A) Southern hybridization blot of XmnI digested chromosomal DNA
from different S. mutans strains belonging to three serotypes (c, e and f). A 267-bp internal SMU.1882 sequence was used as a probe against the
digested DNA. Semi-quantitative RT-PCR analysis (B) and quantitative real-time PCR analysis (C) of S. mutans strain GS-5, its isogenic DcovR strain
(IBS07) and the complementing strain (IBS07/pIB30). (D) Quantitative real-time PCR analysis of SMU.1882 transcript in NG-8, its isogenic DcovR strain
(IBS06) and DcovR complemented with pIB30 (IBS06/pIB30). The expression of SMU.1882 was normalized to the expression level of gyrA as an internal
reference for quantitative real-time PCR analyses.
doi:10.1371/journal.pone.0015528.g004
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transcription. For example, CovR can acts as an anti-silencer of
gene expression. Recently, in Salmonella, it has been shown that
response regulator such as PhoP [40] or SsrB [41] can overcome H-
NS (a nucleoid-binding protein) mediated gene silencing; however,
the exact molecular mechanism by which these response regulators
function as anti-silencers is not yet known. However, it is
conceivable that HLP, an H-NS homolog, can also silence gene
expression in S. mutans and the role of CovR is to overcome the
silencing effect of HLP by replacing it from the promoter. We
believe this scenario is very unlikely since the binding of HLP to
P1882 is non-specific as opposed to the silenced promoters where
HLP binding is specific (data not shown). Furthermore, if a
repressor protein, such as HLP, binds to the intergenic region
between SMU.1882 and SMU.1883, then the expression of
SMU.1883 would also be affected in the covR deleted strain, which
was not the case (Fig. 2A). The SMU.1883 gene encodes a
component of the man-PTS system (ManO) and is highly conserved
among various streptococci [32]. Because other genes of the man-
PTS system are not regulated by CovR in other bacteria [17], we
believe that this gene is not under the CovR regulatory pathway.
The other possibility is that CovR might work alongside other
regulatory proteins in order to interactively regulate the expression
of target genes, similar to RcsB response regulator of Salmonella.I n
this case, RcsB requires a co-activator, RcsA, for the expression of
certain genes such as ugd [42]. On the other hand, a small
molecule can bind to CovR and change its conformation/
oligomerization state such that CovR can act as an activator. A
well-know example of a transcriptional regulator that changes its
conformation upon small molecule binding is TraR of Agrobacterium
tumefaciens. In this case, when the cognate autoinducer ligand binds
to TraR, it changes the conformation and the oligomerization of
the TraR [43]. Further experiments are required to verify whether
CovR interacts with other regulatory proteins or ligands as well as
to understand the molecular mechanism by which CovR activates
the transcription from the SMU.1882 promoter.
At the present time, the exact physiological role of SMU.1882 is
unclear. This gene appears to be found only in S. mutans, but not in
Figure 5. Effect of CovR on transcription from P1882. In vitro
transcription was carried out using P1882 and Pami template DNA
according to the protocol as described in the text. Lanes 1–3: no CovR;
lanes 4–6: increasing concentration of CovR (1, 4, and 10 pmole,
respectively). The experiments were repeated at least twice and a
representative gel is shown.
doi:10.1371/journal.pone.0015528.g005
Figure 6. Potential consensus sequence for CovR binding. (A) WebLogo representation of the position weight matrices derived from five
CovR regulated promoters using GLAM2 [36]. (B) The location of the consensus sequence in the promoter region of the corresponding genes.
doi:10.1371/journal.pone.0015528.g006
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motif at the N-terminal region coupled with the fact that
SMU.1882 is topologically and transcriptionally associated with
an ABC transporter (ComA) strongly suggest that SMU.1882
might encode a bacteriocin related peptide. Inactivation of
SMU.1882 did not produce any noticeable phenotypes when
tested against five streptococcal and one lactococcal species (data
not shown). Analysis of the S. mutans UA159 genome by BAGEL
[44] suggests that this strain encodes at least 26 putative
bacteriocins. Since S. mutans resides in the dental plaque that
contains over 700 different bacterial species [45], it is possible that
for successful colonization and survival, S. mutans may need such a
high number of bacteriocins. Although the target species remain to
be identified, we believe that SMU.1882 is one of such bacteriocin
that may provide a fitness advantage to S. mutans by controlling the
growth of other competing species in the dental plaque.
Materials and Methods
Bacterial strains and growth conditions
Escherichia coli strain DH5a was grown in Luria-Bertani (LB)
medium supplemented (when necessary) with ampicillin (50 or
100 mg/ml) or kanamycin (50 mg/ml). S. mutans strains UA159 and
GS-5, and other mutans isolates, were typically grown in Todd-
Hewitt medium (BBL, Becton Dickson) supplemented with 0.2%
yeast extract (THY). Growth of the S. mutans cultures was
monitored using a Klett-Summerson colorimeter with a red filter.
Extraction of RNA from S. mutans strain UA159
RNA, which was used for various experiments, was isolated
from cultures of S. mutans strains UA159 (and its derivatives) and
GS-5 (and its derivatives), grown to mid-exponential phase (Klett
unit (KU) 70), under the growth conditions specified above. The
cultures were harvested via centrifugation, re-suspended and
incubated in RNA protect reagent (Qiagen) at room temperature
for 30 min, and then re-centrifuged to form a pellet, which was
either stored overnight at 220uC or processed immediately for
RNA extraction. RNA extraction was performed as described by
Biswas et al. [30].
Determination of the stability of the SMU.1882 transcript
of S. mutans
The stability of SMU.1882 mRNA was determined using a
protocol described by Biswas et al. [30]. Upon reaching the desired
optical density (O.D.), the RNA polymerase inhibitor rifampin was
immediately added to each culture to prevent the de novo synthesis
of RNA. RNA was then collected from aliquots of S. mutans at 8
time points, during a total incubation period of 30 minutes at
37uC. At each time point, sodium azide (final concentration:
50 mM) was added to the culture to terminate cellular processes,
and then immediately placed in dry ice. RNA (4 mg) from each
time point was denatured, loaded onto a 1% agarose gel, and
separated via electrophoresis for northern blot analysis. DNA
probes were synthesized via PCR amplification using the primer
pairs Smu1882 F3 and Smu1882 R3 (for a list of primers see
Table 1), with chromosomal DNA of S. mutans UA159 as template.
The probes were labeled using [a-32P] dATP, with a DECApri-
meII kit (Ambion), and added to a hybridization tube containing
the transfer membrane and ULTRAhyb buffer (Ambion), followed
by overnight incubation. Following hybridization, the membrane
was washed according to manufacturer’s instructions, dried, and
exposed to a phosphorimager plate and analyzed using a Typhoon
phosphorimager (Molecular Dynamics).
Semiquantitative and real-time RT-PCR analyses
Semi-quantitative (sq) RT-PCR was used to quantify the level of
expression of various genes in UA159 and GS-5, along with the
respective covR mutant strains. The S. mutans cultures were grown
to mid-exponential phase (KU70), followed by RNA extraction.
sqRT-PCR was performed as previously described [30] using the
Table 1. Primers used in the analysis.
Primer Sequence Function
NlmA-PF TAAACAGCAAAAAGTAATCT PnlmA amplification
NlmA-PR GCGCATATGATAAACACCCC PnlmA amplification
Smu1882F1 GCGCGGATCCTGAATAAATATATTTTATTATATC GusA assay, EMSA, DAP
Smu1882R1 GCGCCTCAGACAGCTTATTCAAACTTGTAGC GusA assay, EMSA, DAP
Smu1882F2 CAGCTATACTGCTGAGGCTCCCTAGATC In vitro transcription
Smu1882R2 TAGCTTTAAAATCTTCAAACGCTTGAC Linkage analysis
Smu1881cR1 CTGAAACTACAGTCAAAAGAAGATAAG Linkage analysis
Smu1882F3 GCTGTCTTATACGACAGGTGGAGCTACTG Southern, northern, sqRT-PCR
Smu1882R3 CCACCTGTCGTATTACTTGAACTACTGC Southern, northern, sqRT-PCR
Smu1882F4 GCAGTAGTTCAAGTAATACGACAGGTGG Linkage analysis
Smu1882R5 CACCATCAGTAGCTCCACCTGTCGTAT In vitro transcription
Smu1883crevF1 CGCCAAGAAGAAATTTTCCCACTTTGCC Linkage analysis
Smu1883crevR1 GGAGCCAATGTCAATCGGAAAAAGGTCAG Linkage analysis
Smu1884cF1 GGTCAGACACCTTATTCTTAAATTGG Linkage analysis
PJRS F TAAGGCTATTGGTGTTTATGGC Pami amplification
PJRS R TACAATTGTCATCACCATTCTT Pami amplification
Smu-Nco-RpoD-F GGGCCATGGTAAATAATAAGAAAAAAACAT-CAAG RpoD expression
Smu-Xho-RpoD-R GCGCTCGAGATCTTCAACAAAATCACGTAACTGC RpoD expression
doi:10.1371/journal.pone.0015528.t001
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included as control to ensure that equivalent amounts of RNA
were being used for each reaction. For real-time RT-PCR, cDNA
was prepared from samples as described above. cDNA levels were
quantified in 7500 Fast real-time PCR machine (Applied
Biosystems). The reactions were performed in 20 ml final volume,
consisting of 1X Fast SYBR Green Master Mix (Applied
Biosystems) and 0.5 mM of each sense and antisense primer pair.
For every primer pair, four different cDNA concentrations were
analysed in duplicate. Cycling conditions were as follows: 95uC for
1 min, followed by 40 cycles of 95uC for 15 s and 60uC for 1 min
with fluorescent measurement at the end of each cycle and one
dissociation step of 95uC for 15 s, 60uC for 30 s and 95uC for 15 s.
gyrA housekeeping gene served as an internal control to normalize
the expression levels between samples. No template controls were
included in all real-time PCR reactions. Standard curves were
plotted (GraphPad Prism) for all three samples using log input
dilution series of K-DNA templates against cycle threshold values
(Ct) of the performed qPCR. Slopes and R
2 values were obtained
and were used to calculate real time PCR reaction efficiencies
[E=10 ˆ(21/slope)]. The relative expression levels were calculated
according to the method developed by Pfaffl [46]. GraphPad
prism software was employed to analyze the experimental data.
The data are presented as mean value +/2 SD.
Construction of CovR deleted strains
To create a covR-deleted strain, we used pIB10 [29] that
contains a 1.7-kb fragment containing the entire covR gene with
flanking regions. A Km resistant cassette with flanking modified
loxP sites, was amplified from pUC4VKm2 [47] using the primers
lox71-Km-F and lox66-Km-R [48] and cloned into the BseRI -
NruI digested and T4-DNA polymerase blunted sites to generate
pIB-601. Plasmid pIB-601 was linearized with EcoRI and
transformed into S. mutans UA159 as previously described [48].
Transformants were selected on THY plates containing Km; one
such transformant was named IBS-601. To eliminate the loxP-Km
r
cassette from the chromosome, IBS-601 was transformed with
pCrePA [48], which expresses the cre recombinase gene from a
temperature-sensitive replicon (pWV01). Subsequently, Em
r and
Km
s colonies were selected; those colonies contain pCrePA and
lost the Km resistance gene from the chromosome. Subsequently,
pCrePA plasmid was cured as described previously to generate
IBS-603, which contains a markerless covR deletion.
To generate covR deletion construct in GS-5 and NG-8, plasmid
pIB26 [29] was used that contains a spectinomycin resistant gene
inserted in the middle of the covR gene. This plasmid was
linearized with NotI and used for S. mutans transformation.
Construction of P1882-gusA reporter strains and
quantification of transcription from P1882
To quantify transcription from P1882 from S. mutans UA159, a
reporter strain was constructed by cloning the putative promoter
region of SMU.1882 into plasmid pIB107 [29], which contains a
promoterless gusA gene. The putative P1882 region was amplified
from S. mutans chromosomal DNA using primers Smu1882 F1 and
Smu1882 R1, which contain BamHI and XhoI sites, respectively
(Table 1). This fragment was digested using BamHI and XhoI, and
cloned into BamHI-XhoI-digested pIB107 [29] to yield plasmid
pIB602, which was then transformed into E. coli DH5a. Plasmid
pIB602 was purified from overnight grown cultures of E. coli
DH5a, linearized with BglI, and used for the transformation of S.
mutans strains UA159 (wild-type), IBS603 (DcovR), and IBS603/
pIB30 (DcovR, complemented with wild-type covR in trans)t o
generate the reporter strains IBS602, IBS606, and IBS606/pIB30,
respectively. The reporter strains were grown to mid-exponential
phase (KU70) in THY broth containing Em to maintain the
complementing plasmid. The cells were harvested via centrifuga-
tion and lysed for b-glucuronidase (GusA) assays, as described by
Biswas et al. [29].
Electrophoretic mobility shift assay (EMSA) and DNase I
protection assay (DPA)
EMSA and DPA were used to demonstrate binding of CovR to
P1882. Primer Smu1882 F1 was labeled with c
32-ATP and, along
with Smu1882 R1, was used to PCR amplify a DNA fragment
containing P1882, with a radiolabel at the 59-end of the fragment.
Each fragment was incubated with various concentrations of 6XHis-
tagged CovR protein in binding buffer (final volume - 50 ml) as
described by Biswas et al. [30]. Following 40–45 minutes incubation,
at ambient room temperature, 10 ml of the nucleo-protein mix was
loaded onto a 4% (29:1) native PAGE gel, buffered with 0.5X TBE
buffer, pH 8.0. The loaded PAGEwas then electrophoresed at room
temperature, in the same buffer for 2 hours, 80 V. The gel was then
dried and exposed to phosphorimager plate and developed using a
Typhoon phosphorimager.
DPA was performed using the same P1882 fragment with or
without CovR. Reactions were prepared similarly to EMSA and
after 40 min incubation, the mixtures were treated with a dilute
DNase I solution (Epicentre) for 5 minutes, as described previously
[30]. The samples were denatured and loaded onto an 8%
denaturing PAGE gel containing urea and buffered with 1X TBE
for electrophoresis. The gel was then dried and exposed to a
phosphorimager plate.
Purification of His-RpoD
To synthesize His-RpoD, an 1127-bp DNA fragment, contain-
ing the entire rpoD gene without its stop codon, was PCR amplified
from chromosomal DNA of S. mutans UA159, using the primer
pair Smu-Nco-RpoD-F and Smu-Xho-RpoD-R. The DNA
fragment was digested with XhoI and NcoI, and cloned into
XhoI/NcoI-digested pET23D (Novagen), generating pIB611. Plas-
mid pIB611 was then transformed into E. coli BL21 DE3 pLysS.
His-RopD was purified on Ni NTA column (Qiagen) following
manufacturer’s protocol and the purified protein was dialyzed
against buffer B.
In vitro transcription (IVT) assay
A DNA fragment containing P1882 was amplified from UA159
genomic DNA by PCR using the primer pair: smu1882-F2 and
smu1882- R5. Similarly, the promoter Pami, which was originally
isolated from a Streptococcus pneumoniae gene that encodes amidase,
was amplified from pIB163 [49]using the primer pair: PJRS-F and
PJRS-R. In vitro transcription assay was carried out with the
desired templates in reaction buffer containing 50 mM Tris-Cl
(pH 7.5), 150 mM NaCl, 2 mM MgCl2, 0.1 mM EDTA, and
0.1 mM DTT in 20 ml volume. CovR (1–10 pmol) was preincu-
bated in the reaction buffer along with the template DNAs for
20 min at room temperature. After incubation, 500 mM each (final
conc.) of ATP, CTP, GTP, and 50 mM UTP with 1.0 mCi of
[a-
32P] UTP [,9000 Ci/mmol] were added to the reaction
mixture. To initiate transcription, 0.25 U E. coli core RNA
polymerase (Epicentre), RpoD (1.0 mg), and RNase inhibitor
(40 U, Promega). After the incubation at 37uC for 15 min,
samples were resolved by electrophoresis in a 4% urea gel.
Transcripts were quantitated by densitometry with the Image-
Quant software (GE Healthcare) by exposing the dried gel on a
phosphorimager plate.
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